Thu, May 22, 2025
Wed, May 21, 2025
Tue, May 20, 2025
[ Tue, May 20th ]: WJHG
Time Travel Tuesday
Mon, May 19, 2025
Sun, May 18, 2025
Sat, May 17, 2025
Fri, May 16, 2025
Thu, May 15, 2025
[ Thu, May 15th ]: fox6now
Expert travel advice
Wed, May 14, 2025
Tue, May 13, 2025
Mon, May 12, 2025

Ozempic CEO's exit from Novo started with Teams call surprise

  Copy link into your clipboard //travel-leisure.news-articles.net/content/2025/ .. -from-novo-started-with-teams-call-surprise.html
  Print publication without navigation Published in Travel and Leisure on by Fortune
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
  "I think that's part of the game, so to say. It's not for me to judge the criteria," Lars Fruergaard Jorgensen said.


Novo Nordisk's CEO, Lars Fruergaard Jørgensen, announced his unexpected departure from the company, effective immediately, as reported by Fortune on May 16, 2025. Jørgensen, who has been at the helm since 2017, led the company through a period of significant growth, particularly with the success of its diabetes and weight-loss drugs, Ozempic and Wegovy. His exit comes as a surprise to the industry, with no specific reason given for his sudden departure. The board has appointed Karsten Munk Knudsen, the current executive vice president and head of commercial strategy and corporate development, as the interim CEO while a search for a permanent replacement is conducted. The transition is expected to be smooth, but investors and analysts are closely watching how this leadership change will impact the company's future strategy and performance.

Read the Full Fortune Article at:
[ https://fortune.com/2025/05/16/novo-nordisk-ozempic-wegovy-ceo-jorgensen-exit-surprise/ ]